Neutralization of pathogenic PC-OxPL by AAV-delivered scFv as a therapeutic strategy for amyotrophic lateral sclerosis.

Gomes-Duarte A, Wong JK, Moro A, Pasteuning-Vuhman S, Pos W, Haselberg R, Sogorb-González M, Pascoal S, Borst L, Chatterjee M, et al.